Cel-Sci
CVM
#9766
Rank
A$78.04 M
Marketcap
A$9.76
Share price
2.54%
Change (1 day)
-62.52%
Change (1 year)

Cel-Sci (CVM) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : A$20.14 Million

According to Cel-Sci 's latest financial reports the company's total liabilities are A$20.14 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Cel-Sci - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30A$20.42 M-24.17%
2023-09-30A$26.93 M-5.64%
2022-09-30A$28.54 M6.75%
2021-09-30A$26.73 M-7.91%
2020-09-30A$29.03 M-12.81%
2019-09-30A$33.3 M-18.69%
2018-09-30A$40.95 M22.35%
2017-09-30A$33.47 M0%
2016-09-30A$33.47 M-29.57%
2015-09-30A$47.52 M372.57%
2014-09-30A$10.05 M126.49%
2013-09-30A$4.44 M-49.14%
2012-09-30A$8.72 M-10.92%
2011-09-30A$9.79 M-5.02%
2010-09-30A$10.31 M-75.91%
2009-09-30A$42.82 M781.65%
2008-09-30A$4.85 M-28.33%
2007-09-30A$6.77 M-52.24%
2006-09-30A$14.18 M991.32%
2005-09-30A$1.3 M-33.03%
2004-09-30A$1.94 M-22.06%
2003-09-30A$2.49 M-50.02%
2002-09-30A$4.98 M382.73%
2001-09-30A$1.03 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Curis
CRIS
A$64.07 M 218.02%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$1.26 B 6,167.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$121.88 B 604,814.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.36 B 1,729.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$49.34 B 244,819.73%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
A$171.86 B 852,852.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$1.32 B 6,499.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$3.93 M-80.45%๐Ÿ‡บ๐Ÿ‡ธ USA